count,diagnosis,group_name,subgroup_name,male count,female count,age mean,age range,age minimum,age maximum,age median,rank,start_char,end_char,pmcid
23,healthy,healthy,MEG Center,,,,,,,,0,5395,7240,8752963
89,healthy,healthy,HCP,44.0,45.0,,22-35,22.0,35.0,,0,5395,7240,8752963
160,healthy,healthy,healthy,115.0,45.0,37.04,19-59,19.0,59.0,,1,10065,11877,7721229
151,SZ,patients,SZ,115.0,36.0,38.77,18-62,18.0,62.0,,1,10065,11877,7721229
284,healthy,healthy,RH,71.0,,26.8,,,,,0,9266,11207,4319399
284,healthy,healthy,LH,73.0,,24.4,,,,,0,9266,11207,4319399
21,PTSD,patients,PTSD patients,,,,,,,,0,7905,9151,5030332
41,UC,patients,UC patients,25.0,16.0,37.1,20-54,20.0,54.0,,0,5613,7441,6457314
42,Healthy,healthy,Healthy controls,25.0,17.0,36.86,22-55,22.0,55.0,,0,5613,7441,6457314
13,"unilateral, upper limb amputation and phantom limb pain",patients,amputees with phantom limb pain,11.0,2.0,52.92,32-75,32.0,75.0,,0,8118,9527,2494616
6,healthy,healthy,healthy volunteers,,,43.0,30-56,30.0,56.0,,0,8118,9527,2494616
10,healthy,healthy,PET/MR visits,,,,,,,,9,10160,12019,4280551
7,healthy,healthy,MR/only visits,,,,,,,,9,10160,12019,4280551
17,healthy,healthy,dexmedetomidine-induced unconsciousness vs awake,,,,,,,,9,10160,12019,4280551
11,proficient,patients,proficient,3.0,8.0,28.73,19-46,19.0,46.0,,0,39775,41437,3554651
10,less-proficient,patients,less-proficient,3.0,7.0,30.0,19-45,19.0,45.0,,0,39775,41437,3554651
32,healthy,healthy,all,17.0,15.0,,25-27,25.0,27.0,,0,4501,6030,4332461
18,naive subjects,healthy,naive subjects,,,,,,,,0,24448,24931,2995581
11,healthy,healthy,total,,6.0,31.0,25-38,25.0,38.0,,0,7753,8593,3132672
30,"first-episode, drug-nave MDD",patients,MDD patients,9.0,21.0,,18 and 45 years,18.0,45.0,,0,6957,8726,4869560
29,healthy,healthy,healthy subjects,15.0,14.0,26.76,,,,,0,6957,8726,4869560
60,pedophiles with child sexual abuse,patients,group one,,,,,,,,0,20137,21509,6678781
12,healthy,healthy,total,,7.0,25.8,,,,,1,8416,8816,7649291
20,MdDS,patients,MdDS patients,5.0,15.0,43.4,27-66,27.0,66.0,,0,12585,13447,3510214
20,healthy,healthy,Control group,,,43.0,23-59,23.0,59.0,,0,12585,13447,3510214
21,idiopathic PD,patients,idiopathic PD,14.0,7.0,,,,,,0,6018,7316,3045463
19,healthy,healthy,healthy adults,12.0,7.0,,,,,,0,6018,7316,3045463
17,,healthy,children,,9.0,7.4,6.9-7.8,6.9,7.8,,0,14497,15232,3780305
18,lung cancer,patients,lung cancer patients,,,,48-70,48.0,70.0,,0,8631,10461,7275001
21,healthy,healthy,healthy controls,,,,48-70,48.0,70.0,,0,8631,10461,7275001
15,healthy,healthy,male,15.0,,22.33,,,,,0,6364,7265,4838249
157,"Substance use disorders, Major depression",patients,incarcerated,,157.0,,18-50,18.0,50.0,,0,7405,9404,4174863
46,No history of alcohol or drug disorder,healthy,non-incarcerated,,46.0,,18-50,18.0,50.0,,0,7405,9404,4174863
24,healthy,healthy,healthy participants,,,57.0,,,,,0,9842,10239,5903407
40,healthy,healthy,male,24.0,,68.4,,,,,0,6784,7467,5717028
40,healthy,healthy,female,,16.0,68.4,,,,,0,6784,7467,5717028
13,chronic pain,patients,chronic pain group,4.0,9.0,51.8,43 to 65,43.0,65.0,,0,8990,10646,4048172
13,no chronic pain,healthy,"normal, control group",4.0,9.0,48.7,38 to 62,38.0,62.0,,0,8990,10646,4048172
66,AN,patients,AN-R,,66.0,,,,,,0,7409,9049,3913832
35,Healthy,healthy,,,35.0,,,,,,0,7409,9049,3913832
7,healthy,healthy,male,7.0,,23.5,21-28,21.0,28.0,,0,8419,8773,7406917
29,healthy,healthy,healthy volunteers,,,,,,,,0,9392,10386,7563756
24,healthy,healthy,all participants,10.0,,34.5,,,,,0,8940,9612,8699602
50,relapsing-remitting MS,patients,,,,,18 to 55,18.0,55.0,,0,7655,8461,6200185
25,healthy,healthy,,,,,18 to 55,18.0,55.0,,0,7655,8461,6200185
28,healthy,healthy,all,15.0,13.0,26.39,,,,,0,8040,9242,7481390
26,happy,healthy,happy group,,,,,,,,1,6340,7837,3893192
25,unhappy,healthy,unhappy group,,,,,,,,1,6340,7837,3893192
5,intrinsic tumours within the right cerebral hemisphere,patients,not specified,2.0,3.0,33.7,not specified,,,,0,5975,7741,6699415
19,obsessivecompulsive-disorder (300.3),patients,,,,,,,,,2,6638,8486,3777673
19,,healthy,,,,,,,,,2,6638,8486,3777673
167,ADHD,patients,children and adolescents,,,,,,,,1,16953,18603,8782893
6,"PCH (type 10,7,11)",patients,"PCH (type 10,7,11)",3.0,2.0,7.33,,,,,2,10310,12308,9461104
63,healthy,healthy,GnRHa group,,30.0,24.3,,,,,0,5351,7071,5068584
63,healthy,healthy,placebo group,,26.0,24.3,,,,,0,5351,7071,5068584
50,IPD,patients,IPD patients,,,,,,,,0,4609,5604,6675526
20,healthy,healthy,healthy controls,11.0,9.0,54.6,,,,,0,4609,5604,6675526
20,neurologically healthy,healthy,Swedish speakers,,,,,,,,0,7547,7912,4477935
20,neurologically healthy,healthy,English speakers,,,,,,,,0,7547,7912,4477935
30,healthy,healthy,all participants,,21.0,230.41,,,,,0,8670,9696,8018944
18,nAMD,patients,nAMD patients,9.0,9.0,,55 years old and above,55.0,,,1,16185,17940,8544331
18,Healthy,healthy,Healthy controls,9.0,9.0,,,,,,1,16185,17940,8544331
22,healthy,healthy,total,13.0,9.0,26.7,18-60,18.0,60.0,22.5,0,7644,8859,2775905
36,healthy,healthy,Experiment 1,10.0,8.0,26.3,21-41,21.0,41.0,,0,12247,13506,3869681
36,healthy,healthy,Experiment 2,9.0,9.0,26.6,21-38,21.0,38.0,,0,12247,13506,3869681
54,CUD,patients,CUs,,,,18-45,18.0,45.0,,1,7650,8658,8459240
54,nonCUD,healthy,nonCUs,,,,18-45,18.0,45.0,,1,7650,8658,8459240
29,healthy,healthy,Information Systems students,,13.0,23.6,21-33,21.0,33.0,,0,44675,45771,7989009
21,BDD,patients,BDD patients,,,,16 to 48,16.0,48.0,,0,7306,8855,6246657
40,MDD,patients,MDD patients,,,,16 to 48,16.0,48.0,,0,7306,8855,6246657
70,healthy,healthy,healthy controls,,,,16 to 48,16.0,48.0,,0,7306,8855,6246657
21,healthy,healthy,male,21.0,,25.77,20-40,20.0,40.0,,0,7315,8159,5776089
1418,healthy,healthy,discovery sample,,,22.39,18-35,18.0,35.0,,0,24189,25345,9564100
473,healthy,healthy,replication sample,,,,,,,,0,24189,25345,9564100
20,healthy,healthy,all participants,14.0,6.0,24.0,20-34,20.0,34.0,,0,15910,17003,8764488
24,without a history of neurological or psychological complications,healthy,Study 1,,24.0,24.0,20-30,20.0,30.0,,0,13949,14774,3965851
18,Selection criteria were identical to Experiment 1,healthy,Study 2,,18.0,24.0,20-30,20.0,30.0,,0,13949,14774,3965851
15,healthy,healthy,all,5.0,10.0,31.69,22-54,22.0,54.0,,0,9579,10553,7981326
30,HFS,patients,HFS patients,12.0,18.0,48.87,,,,,1,6781,8456,8569140
30,healthy,healthy,healthy controls,12.0,18.0,47.63,,,,,1,6781,8456,8569140
31,drug-nave/free first episode psychosis (FEP),patients,FEP patients,26.0,5.0,26.64,,,,,0,5892,6567,8550949
35,healthy,healthy,healthy volunteers,26.0,9.0,27.12,,,,,0,5892,6567,8550949
12,healthy,healthy,males,12.0,,31.0,18-55,18.0,55.0,,0,6311,6921,3258233
42,healthy,healthy,male,42.0,,23.86,19-32,19.0,32.0,,0,10534,11508,4380440
23,young people with a history of childhood abuse,patients,young people with a history of childhood abuse,,,,,,,,0,12106,13458,5104469
20,psychiatric controls,patients,psychiatric controls,,,,,,,,0,12106,13458,5104469
27,healthy controls,healthy,healthy controls,,,,,,,,0,12106,13458,5104469
10,IMP and juvenile fibromyalgia,patients,IMP patients,1.0,9.0,16.3,14-17,14.0,17.0,,1,7085,9081,5686883
10,healthy,healthy,control group,1.0,9.0,16.1,14-17,14.0,17.0,,1,7085,9081,5686883
17,schizophrenia or schizoaffective disorder,patients,schizophrenia,,,,,,,,0,9651,11638,7851842
18,no history of any mental disorders,healthy,healthy controls,,,,,,,,0,9651,11638,7851842
24,no history of neurological problems,healthy,all participants,12.0,12.0,25.3,21-34,21.0,34.0,,0,12556,14217,7994216
17,No neurological or psychiatric history,healthy,All participants,5.0,12.0,24.0,18-31,18.0,31.0,,0,15536,16064,5902547
13,DCG,patients,DCG,5.0,8.0,23.1,,,,,0,13409,14663,4034409
13,TCG,patients,TCG,4.0,9.0,23.5,,,,,0,13409,14663,4034409
12,cockroach phobia,patients,cockroach phobia,4.0,8.0,40.08,,,,,0,5977,7136,6220927
12,no phobia,healthy,no phobia,4.0,8.0,24.08,,,,,0,5977,7136,6220927
10,chronic marijuana users,patients,MJ users,8.0,,,,,,,0,7512,9453,3742334
18,nonusing comparison subjects,healthy,NU subjects,11.0,,,,,,,0,7512,9453,3742334
31,healthy,healthy,controls,,,21.5,,,,,2,10037,11997,5339238
14,FIDA,patients,FIDA,,,,,,,,2,10037,11997,5339238
66,TLE patients with unilateral hippocampal sclerosis,patients,TLE patients with unilateral hippocampal sclerosis,,,,,,,,1,8349,9763,8933317
31,Healthy controls,healthy,Healthy controls,,,,,,,,1,8349,9763,8933317
13,right MCA territory infarction,patients,male,13.0,,,,,,,0,4472,5608,8154462
11,healthy,healthy,male,11.0,,,,,,,0,4472,5608,8154462
24,healthy,healthy,University of Wrzburg,12.0,12.0,26.0,23 to 34,23.0,34.0,,0,6711,7624,3502502
46,healthy,healthy,Oxford Centre for Functional MRI of the Brain,21.0,25.0,30.0,19 to 63,19.0,63.0,,0,6711,7624,3502502
19,MTLE,patients,MTLE patients,11.0,8.0,45.3,unknown,,,,0,7759,9339,7836234
19,healthy,healthy,healthy controls,10.0,9.0,45.8,unknown,,,,0,7759,9339,7836234
15,healthy,healthy,students,7.0,,23.8,,,,,0,5173,6802,5324609
15,healthy,healthy,all participants,8.0,7.0,,,,,,0,22735,23247,2390848
58,free from self-reported life-time psychiatric or neurological disease and medication,healthy,right-handed,26.0,32.0,24.02,,,,,0,6544,7179,3492343
216,"No history of genetic psychiatric or neurological illness, psychiatric treatment, or drug or alcohol abuse",healthy,Chinese Han populations,,,,,,,,0,5902,6887,8828908
38,healthy,healthy,working with children,9.0,10.0,24.08,,,,,0,8721,10120,7395771
38,healthy,healthy,not working with children,9.0,10.0,24.08,,,,,0,8721,10120,7395771
26,healthy,healthy,total,12.0,14.0,23.04,18-35,18.0,35.0,,0,7141,8906,6697392
19,MDD,patients,MDD patients,,,,18-55,18.0,55.0,,0,7093,8833,7875881
17,Healthy,healthy,Healthy controls,,,,18-55,18.0,55.0,,0,7093,8833,7875881
6,normal hearing levels in both ears,healthy,young adults,5.0,1.0,,22 to 35 years,22.0,35.0,,0,10745,11773,3894920
33,ASD,patients,children and adolescents with ASD,,,,10 to 17,10.0,17.0,,0,9508,11142,5870086
10,,healthy,undergraduate and graduate students,4.0,6.0,20.8,,,,,0,11679,12501,6528067
23,MTLE,patients,LMTLE,,,,,,,,2,7220,9208,8933759
23,MTLE,patients,RMTLE,,,,,,,,2,7220,9208,8933759
23,healthy,healthy,controls,,,,,,,,2,7220,9208,8933759
29,healthy,young adults,young adults,,19.0,23.8,19-30,19.0,30.0,,0,8764,10050,8318202
32,healthy,older adults,older adults,,17.0,71.0,65-81,65.0,81.0,,0,8764,10050,8318202
17,DLB,patients,DLB patients,13.0,,71.88,60-82,60.0,82.0,,1,6917,8222,6902076
20,Healthy,healthy,healthy subjects,9.0,,67.8,56-77,56.0,77.0,,1,6917,8222,6902076
37,Parkinson's Disease,patients,PD patients,17.0,,,,,,,1,6434,8193,4184784
34,Healthy,healthy,healthy controls,22.0,,,,,,,1,6434,8193,4184784
18,healthy,healthy,all participants,10.0,,25.0,22-29,22.0,29.0,,0,8993,9484,4493392
220,,patients,adolescents,115.0,,14.61,14-15,14.0,15.0,,1,7509,9204,3991323
28,,healthy,adults,17.0,,25.24,20-39,20.0,39.0,,1,7509,9204,3991323
163,healthy,healthy,HC,,,,,,,,0,32244,34337,9057100
151,schizophrenia,patients,SZ,,,,,,,,0,32244,34337,9057100
16,ASD,patients,ASD male participants,16.0,,,8-18,8.0,18.0,,0,7481,9124,5279905
16,TD,healthy,TD participants,,,,,,,,0,7481,9124,5279905
233,healthy,healthy,all participants,,117.0,16.1,9.9-26.6,9.9,26.6,,0,6438,8339,5390693
24,FD-PDS-MDD,patients,FD-PDS-MDD,,24.0,42.44,,,,,2,18065,18709,7518235
24,FD-PDS,patients,FD-PDS,,24.0,42.44,,,,,2,18065,18709,7518235
24,,healthy,HC,,24.0,42.44,,,,,2,18065,18709,7518235
45,smokers,patients,smokers,,,,,,,,0,3425,4639,3511796
44,non-smokers,healthy,non-smokers,,,,,,,,0,3425,4639,3511796
32,chronic left-hemisphere stroke,patients,stroke patients,27.0,5.0,62.0,18-75,18.0,75.0,,0,8398,9988,4473263
18,healthy,healthy,healthy volunteers,8.0,10.0,63.0,18-75,18.0,75.0,,0,8398,9988,4473263
21,ET patients,patients,ET patients,12.0,,51.6,,,,,1,16041,17271,4732188
21,Healthy controls,healthy,Healthy controls,14.0,,50.6,,,,,1,16041,17271,4732188
20,healthy,healthy,all,12.0,8.0,24.4,19-35,19.0,35.0,,0,7853,8437,3147157
19,healthy,healthy,total,13.0,,,18-40,18.0,40.0,,0,37350,38168,6787094
16,healthy,healthy,included in analyses,,,,,,,,0,37350,38168,6787094
47,healthy,healthy,undergraduate students,,47.0,19.62,,,,,0,7835,9127,5548834
55,,healthy,White male participants,55.0,,24.255,18-35,18.0,35.0,,0,30465,32004,6434022
40,healthy,healthy,male,20.0,,20.0,18-23,18.0,23.0,,0,11424,11801,4370584
40,healthy,healthy,female,,,20.0,18-23,18.0,23.0,,0,11424,11801,4370584
14,healthy,healthy,total,,8.0,24.8,22-29,22.0,29.0,,0,10341,10716,3078751
15,healthy,healthy,healthy volunteers,8.0,7.0,26.5,21-38,21.0,38.0,,0,9056,10789,3324921
23,healthy,healthy,healthy controls,15.0,8.0,31.16,19-44,19.0,44.0,,0,7481,8731,5761874
25,temporal lobe epilepsy,patients,TLE patients,13.0,12.0,33.67,20-45,20.0,45.0,,0,7481,8731,5761874
63,healthy,healthy,total,36.0,27.0,,2255 or 3711,,,,0,10518,11796,7913329
25,healthy,healthy,healthy,14.0,10.0,33.2,,,,,0,9389,11304,6412974
18,JME,patients,JME,3.0,15.0,30.1,20-48,20.0,48.0,,0,9389,11304,6412974
31,healthy,healthy,all participants,16.0,15.0,,18-22,18.0,22.0,,0,18645,19836,3539852
38,ADHD,patients,ADHD,18.0,20.0,,,,,,0,7742,9499,6347794
27,SAD,patients,unmedicated adults,15.0,12.0,,,,,,0,8770,10545,4029608
27,No lifetime history of psychiatric disorders,healthy,HC,14.0,13.0,,,,,,0,8770,10545,4029608
90,VPT,patients,VPT individuals,,,,,,,,1,10731,12742,4215530
22,CT,healthy,Control individuals,,,,,,,,1,10731,12742,4215530
20,healthy,healthy,male,20.0,,23.9,18-33,18.0,33.0,,0,5627,6165,4255751
90,nonusing controls,healthy,CON,,,,,,,,0,8377,10336,7416060
54,chronic cannabis users,patients,CAN,,,,,,,,0,8377,10336,7416060
24,AN,patients,AN,,,,,,,,0,9512,10265,4530666
25,HC,healthy,HC,,,,,,,,0,9512,10265,4530666
70,healthy,healthy,total,25.0,45.0,,12-14,12.0,14.0,,0,6753,7414,7057279
55,healthy,healthy,final,17.0,38.0,13.082,,,,,0,6753,7414,7057279
42,PD,patients,PD patients,,,,,,,,0,8216,9580,6389716
40,NC,healthy,normal controls,,,,,,,,0,8216,9580,6389716
33,healthy,healthy,all participants,17.0,16.0,26.0,20-48,20.0,48.0,,0,9581,10407,5447679
20,healthy,healthy,all,,11.0,21.95,18-35,18.0,35.0,,0,9482,10858,4810172
39,healthy,healthy,students,21.0,18.0,21.33,18-24,18.0,24.0,,0,7186,8239,8152834
17,healthy,healthy,male,17.0,,23.8,20-30,20.0,30.0,,0,9829,10487,3866656
5,TS,patients,TS patients,3.0,2.0,27.0,,,,,0,6603,7746,5857897
113,,healthy,behavioral analysis,,,17.11,12.27 to 21.96,12.27,21.96,,0,8212,9449,7038454
104,,healthy,neuroimaging,,,,,,,,0,8212,9449,7038454
595,,healthy,,,,39.47,883,,,,0,7078,8212,8615904
34,schizophrenia,patients,unmedicated patients with schizophrenia,,,,,,,,0,6605,8461,5292583
35,healthy,healthy,healthy controls,,,,,,,,0,6605,8461,5292583
12,,healthy,first experiment,6.0,6.0,26.0,23-39,23.0,39.0,,0,8558,9073,3422286
14,,healthy,second experiment,7.0,7.0,23.0,24-30,24.0,30.0,,0,8558,9073,3422286
24,MSA c-type,patients,MSA c-type patients,,,,,,,,0,27477,29306,7485713
20,healthy,healthy,controls,,,,,,,,0,27477,29306,7485713
74,healthy,healthy,adolescents,,,,13-18,13.0,18.0,,0,7716,8857,8379626
23,,healthy,,11.0,12.0,24.2,18-31,18.0,31.0,,0,11102,11949,4436102
8,healthy,healthy,all,4.0,4.0,31.75,,,,,0,34627,36506,4522562
100,FES patients,patients,FES patients,,,,,,,,3,9368,11341,9435010
50,Healthy controls,healthy,Healthy controls,,,,,,,,3,9368,11341,9435010
19,healthy,healthy,healthy controls,8.0,11.0,33.0,20-52,20.0,52.0,,0,10079,10652,4983635
53,T2DM,patients,T2DM patients,,,,45 to 75,45.0,75.0,,0,7017,8665,7829678
39,Healthy,healthy,HC group,,,,,,,,0,7017,8665,7829678
14,congenitally profoundly deaf,patients,CS group,3.0,11.0,25.0,18-33,18.0,33.0,,1,25055,26622,5371603
15,normally hearing,healthy,NH group,6.0,9.0,25.17,20-37,20.0,37.0,,1,25055,26622,5371603
45,healthy,healthy,total,18.0,27.0,24.49,,,,,0,26550,27302,5428836
9,healthy,healthy,musicians,6.0,3.0,,19-27,19.0,27.0,,0,36231,37409,5719057
10,ET,patients,ET patients,6.0,,69.48,,,,,0,43154,44585,7493988
10,healthy,healthy,healthy subjects,5.0,,67.7,,,,,0,43154,44585,7493988
19,healthy,healthy,all,12.0,7.0,27.9,,,,,0,7752,8584,7456884
32,no current or previous diagnosis of any neurological or psychiatric disorders,healthy,NCs,,,,,,,,3,8319,9916,6350268
173,TSC,patients,,,,,,,,,0,5201,6435,9308181
23,No chronic psychiatric disorder,healthy,community-dwelling young men,23.0,,29.96,,,,,0,4925,6082,9548384
65,idiopathic PD,patients,PD patients,,,,,,,,0,3039,4402,5655292
24,healthy,healthy,healthy controls,,,,,,,,0,3039,4402,5655292
20,healthy,healthy,undergraduate and postgraduate students,10.0,10.0,22.3,19-28,19.0,28.0,,0,9427,10109,7002496
57,typically developing children without reading disorders,healthy,children,31.0,26.0,10.19,,,,,1,8182,9167,7099000
76,APOE genotype,patients,APOE-4 carriers,60.0,16.0,49.9,40-60,40.0,60.0,,0,45406,47325,9205431
38,APOE genotype,patients,noncarriers,,22.0,,,,,,0,45406,47325,9205431
15,healthy,healthy,men,15.0,,26.0,,,,,0,8450,9492,5270359
21,healthy,healthy,Exp. 1,12.0,,26.0,,,,,0,45697,46616,4458841
22,healthy,healthy,Exp. 2,7.0,,28.0,,,,,0,45697,46616,4458841
28,healthy,healthy,younger adults,19.0,9.0,24.39,18-34,18.0,34.0,,2,9185,9762,7004957
24,healthy,healthy,older adults,15.0,9.0,66.95,55-75,55.0,75.0,,2,9185,9762,7004957
40,healthy,healthy,total,32.0,8.0,20.5,18-28,18.0,28.0,,0,12059,12659,3605341
35,DD,patients,DD children,,,,8-11,8.0,11.0,,1,12349,14111,5758587
35,TD,patients,TD children,,,,8-11,8.0,11.0,,1,12349,14111,5758587
30,healthy,students,Guangdong University of Foreign Studies,10.0,,,18-25,18.0,25.0,,0,15988,17865,5881103
100,multi-problem young adults,patients,multi-problem young adults,,,,,,,,0,7938,9518,6004505
22,healthy,healthy,controls,,,,,,,,0,7938,9518,6004505
53,mTBI,patients,mTBI patients,25.0,28.0,,20-58,20.0,58.0,,0,6826,8200,7539836
43,healthy,healthy,healthy control,19.0,24.0,,20-59,20.0,59.0,,0,6826,8200,7539836
24,Internet Addiction,patients,IA,14.0,10.0,20.58,,,,,0,8544,9896,8939409
23,Healthy Control,healthy,HC,10.0,13.0,21.13,,,,,0,8544,9896,8939409
18,healthy,healthy,female,,18.0,21.04,,,,,0,6805,7868,4975394
28,ASD,patients,ASD with normal IQ,20.0,8.0,14.58,,,,,0,13173,14739,8213933
27,TD,healthy,TD-matched controls,18.0,9.0,14.49,,,,,0,13173,14739,8213933
48,healthy,healthy,male,24.0,,26.4,,,,,0,19298,19503,2993660
48,healthy,healthy,female,,24.0,26.4,,,,,0,19298,19503,2993660
17,healthy,healthy,female,,17.0,20.7,18-23,18.0,23.0,,0,12232,14191,6688454
10,healthy,healthy,total,7.0,3.0,26.6,,,,,0,8471,9034,8893203
20,healthy,healthy,initial,10.0,,31.56,,,,,0,7719,8450,6726765
18,healthy,healthy,final,9.0,,30.34,,,,,0,7719,8450,6726765
43,MDD,patients,MDD patients,13.0,30.0,,,,,,0,8471,10050,7118554
56,healthy,healthy,healthy controls,30.0,26.0,,,,,,0,8471,10050,7118554
20,healthy,healthy,native English speaking children,,,5.8,5.2 to 6.8 years,5.2,6.8,,1,12283,13600,4274095
35,SCD,patients,SCD patients,,,,,,,,1,5511,6530,7090024
32,healthy,healthy,healthy control subjects,,,,,,,,1,5511,6530,7090024
14,healthy,healthy,initial,5.0,9.0,27.0,,,,,0,8869,9939,6198067
11,healthy,healthy,final,7.0,4.0,28.0,,,,,0,8869,9939,6198067
16,healthy,healthy,total,,8.0,25.6,22-30,22.0,30.0,,0,16355,17140,3889700
20,healthy,healthy,initial group,9.0,11.0,,21 to 31,21.0,31.0,,0,7291,8667,8837589
17,healthy,healthy,final group,7.0,10.0,,,,,,0,7291,8667,8837589
29,healthy,healthy,all participants,,14.0,34.5,,,,,0,7334,7745,6868994
103,healthy,healthy,all participants,52.0,51.0,32.5,,,,,0,8117,9983,3334814
18,ASC,patients,ASC,,,30.4,,,,,0,10617,12494,4265725
18,TD,healthy,TD,,,28.6,,,,,0,10617,12494,4265725
34,healthy,healthy,German subjects,12.0,12.0,,23-45,23.0,45.0,,0,5998,7677,2525845
21,Parkinson's disease,patients,Parkinson's disease patients,13.0,,60.8,44-73,44.0,73.0,,0,5559,6387,3182403
204,healthy,healthy,students,,,,,,,,0,6198,7146,3791281
24,healthy,healthy,selected students,,,,,,,,0,6198,7146,3791281
53,mTBI,patients,mTBI patients,,,,,,,,1,14037,15646,7275020
37,healthy,healthy,healthy controls,,,,,,,,1,14037,15646,7275020
15,healthy,healthy,total,8.0,,22.21,,,,,0,13097,13950,6195265
52,pED,patients,pED patients,52.0,,26.85,,,,,0,7554,9492,6290711
52,Normal,healthy,Normal controls,52.0,,28.5,,,,,0,7554,9492,6290711
13,healthy,healthy,total,,7.0,28.4,19-45,19.0,45.0,,0,7494,8254,7430162
19,younger adults,patients,younger adults,5.0,14.0,22.62,18-27,18.0,27.0,,0,12986,14447,3660406
15,older adults,patients,older adults,5.0,10.0,61.15,51-71,51.0,71.0,,0,12986,14447,3660406
24,,healthy,Experiment 1,9.0,,,,,,,3,11174,13042,6016936
24,,healthy,Experiment 2,,,,,,,,3,11174,13042,6016936
4,,healthy,Supplementary Experiment,,,,,,,,3,11174,13042,6016936
17,TS,patients,TS subjects,,,,,,,,7,10133,11399,3877773
15,HC,healthy,HC subjects,,,,,,,,7,10133,11399,3877773
10,healthy,healthy,all,7.0,,27.72,,,,,0,7975,8487,4029023
14,normal hearing,healthy,listeners,7.0,7.0,,22-48,22.0,48.0,,0,9587,10771,3788350
20,healthy,healthy,right-handed,4.0,6.0,25.82,,,,,0,39930,40678,2561002
20,healthy,healthy,left-handed,3.0,7.0,25.23,,,,,0,39930,40678,2561002
32,healthy,healthy,young subjects,,,,25-27,25.0,27.0,,0,7227,8372,5890144
41,,healthy,Christians,22.0,19.0,,,,,,0,27598,28231,2748718
41,,healthy,Nonbelievers,22.0,19.0,,,,,,0,27598,28231,2748718
42,bronchial asthma without acute attacks,patients,completed GCBT,7.0,10.0,50.76,,,,,0,5950,6820,5394595
60,,healthy,,,,,,,,,0,5950,6820,5394595
56,football enthusiasts,patients,Porto or Acadmica supporters,54.0,2.0,34.4,21 to 60,21.0,60.0,,0,6967,8342,5460049
10,,healthy,male,5.0,,29.8,23 to 43,23.0,43.0,,0,19626,20086,3407245
10,,healthy,female,,5.0,29.2,23 to 43,23.0,43.0,,0,19626,20086,3407245
17,aMCI and mAD,patients,aMCI,4.0,7.0,,,,,,1,7688,9501,7838677
6,mAD,patients,mAD,4.0,2.0,,,,,,1,7688,9501,7838677
28,healthy,healthy,control,14.0,14.0,,55-81,55.0,81.0,,1,7688,9501,7838677
34,Alcohol Dependence,patients,ADP,34.0,,,,,,,0,10741,12545,5413198
26,Healthy,healthy,HC,26.0,,,,,,,0,10741,12545,5413198
15,phobic prone (PP),patients,PP,9.0,6.0,39.2,,,,,2,8340,11061,3002948
15,eating disorders prone (EDP),patients,EDP,10.0,5.0,34.4,,,,,2,8340,11061,3002948
53,SAD,patients,SAD patients,,17.0,29.9,,,,,0,5666,7266,4416052
33,healthy,healthy,Control participants,,14.0,29.4,,,,,0,5666,7266,4416052
18,neurologically healthy,healthy,University of Gothenburg,9.0,,,20-32,20.0,32.0,,0,6580,6988,4318429
70,healthy,healthy,total,41.0,,,21-50,21.0,50.0,,0,31013,33118,7260173
54,healthy,healthy,experimental,22.0,,33.58,21-50,21.0,50.0,,0,31013,33118,7260173
15,healthy,healthy,control,7.0,,34.5,,,,,0,31013,33118,7260173
17,PD,patients,PD patients,2.0,,,,,,,0,30658,32637,6382839
17,HC,healthy,HC,4.0,,,,,,,0,30658,32637,6382839
36,No participants reported a history of neurological disorders or current use of steroid medication.,patients,older-aged participants,16.0,20.0,73.2,56-83,56.0,83.0,,0,11922,13361,7779563
2785,,healthy,visual similarity rating task,616.0,569.0,30.1,18-53,18.0,53.0,,0,59945,61874,5832413
1600,,healthy,semantic feature generation task,852.0,748.0,31.7,18-58,18.0,58.0,,0,59945,61874,5832413
16,,healthy,fMRI task,,10.0,23.1,19-29,19.0,29.0,,0,59945,61874,5832413
8,right-sided cerebral palsy,patients,right-sided cerebral palsy patients,3.0,5.0,,13-30,10.0,30.0,,1,7912,9122,6878729
21,problematic tinnitus,patients,problematic tinnitus patients,10.0,11.0,,21-72,21.0,72.0,,0,7425,9376,6667657
18,IA,patients,IA patients,,,15.1,,,,,0,12909,14341,4030253
23,healthy,healthy,healthy controls,,,15.2,,,,,0,12909,14341,4030253
26,AIS,patients,AIS,,,13.02,,,,,1,21631,22584,8785614
26,PVI,patients,PVI,,,11.93,,,,,1,21631,22584,8785614
31,Control,healthy,Control,,,13.25,,,,,1,21631,22584,8785614
19,healthy,healthy,all participants,10.0,9.0,22.8,19-31,19.0,31.0,,0,5579,6473,3869649
22,healthy,healthy,Control group,16.0,6.0,16.0,12-20,,,,0,11779,13692,3701149
12,subclinical AHs,patients,AH group,5.0,7.0,15.97,12-20,,,,0,11779,13692,3701149
13,22q11.2 Deletion Syndrome,patients,22q11.2DS group,,,,12-20,,,,0,11779,13692,3701149
13,experienced HA users,patients,eHA,,,,60-80,60.0,80.0,,0,8835,10592,6509414
14,inexperienced HA users,patients,iHA,,,,60-80,60.0,80.0,,0,8835,10592,6509414
33,healthy,healthy,all,17.0,16.0,25.3,,,,,0,3877,4423,3676955
23,healthy,healthy,behavioral experiment,4.0,19.0,27.69,,,,,0,59146,59841,2144768
18,healthy,healthy,fMRI experiments,9.0,9.0,23.67,19-35,19.0,35.0,,0,59146,59841,2144768
34,neurologically healthy,healthy,all participants,,17.0,24.9,20-38,20.0,38.0,,0,12647,13860,6646524
33,healthy,healthy,all participants,,15.0,25.24,,,,,0,46685,47319,7156375
46,healthy,healthy,behavioral study,,,,18-30,18.0,30.0,,0,13846,15500,3672681
32,healthy,healthy,fMRI study,,,23.0,19-30,19.0,30.0,,0,13846,15500,3672681
25,healthy,healthy,all participants,8.0,17.0,,23-41,23.0,41.0,,0,28089,29258,3483694
23,refractory epilepsy of the temporal lobe,patients,LMTLE group,8.0,15.0,,,,,,2,7012,8935,4017227
23,refractory epilepsy of the temporal lobe,patients,RMTLE group,,,,,,,,2,7012,8935,4017227
19,healthy,healthy,,10.0,9.0,,,,,,2,7012,8935,4017227
11,major depressive disorder (MDD) and BPD depression,patients,depressed patients,5.0,6.0,618.0,,,,,0,6061,7568,4589842
11,healthy,healthy,healthy volunteers,5.0,6.0,568.0,,,,,0,6061,7568,4589842
10,healthy,healthy,total,3.0,7.0,39.8,18-50,18.0,50.0,,0,7096,7923,2935390
18,smokers,patients,Chinese smokers,18.0,,25.11,21-33,21.0,33.0,,2,8569,9966,3409150
12,healthy,healthy,male,7.0,,38.0,23-60,23.0,60.0,,0,7661,9066,4075342
12,healthy,healthy,female,,,,,,,,0,7661,9066,4075342
60,heroin relapser,patients,heroin relapser,,,,,,,,0,7250,8174,4990879
60,non-relapser,patients,non-relapser,,,,,,,,0,7250,8174,4990879
12,healthy,healthy,young adults,8.0,4.0,25.2,,,,,0,8877,10811,6585311
10,chronic post-stroke hemiparesis,patients,individuals with chronic post-stroke hemiparesis,6.0,4.0,66.7,,,,,0,8877,10811,6585311
9,healthy,healthy,age-matched control participants,4.0,5.0,64.2,,,,,0,8877,10811,6585311
39,aphasia,patients,aphasia group,,,,,,,,0,11355,12649,5266856
37,healthy,healthy,control group,,,,,,,,0,11355,12649,5266856
43,healthy,healthy,MRI participants,10.0,21.0,24.3,20-29,20.0,29.0,,0,10334,11086,6847157
42,ASD,patients,ASD,,,,8-36,8.0,36.0,,0,11123,13089,3842522
48,TD,healthy,TD,,,,8-36,8.0,36.0,,0,11123,13089,3842522
134,,healthy,,72.0,62.0,5.34,5.08-5.22,5.08,5.22,,0,11417,12550,9108497
6,Affective Violence,patients,VA group,6.0,,,,,,,1,4708,5988,9230060
7,Predatory Violence,patients,VP group,7.0,,,,,,,1,4708,5988,9230060
7,Non-violent Crime,patients,NV group,7.0,,,,,,,1,4708,5988,9230060
20,Healthy,healthy,HC group,20.0,,,,,,,1,4708,5988,9230060
21,healthy,healthy,initial group,8.0,,24.9,19-30,19.0,30.0,,0,9582,10592,5218407
20,healthy,healthy,after first exclusion,8.0,,25.1,19-30,19.0,30.0,,0,9582,10592,5218407
17,healthy,healthy,after second exclusion,7.0,,25.0,19-30,19.0,30.0,,0,9582,10592,5218407
16,healthy,healthy,total,10.0,,30.1,18-40,18.0,40.0,,0,12442,12867,4072722
19,obesity,patients,obese women,,19.0,,35-55,35.0,55.0,,0,8516,10261,5537800
272,healthy,healthy,female,,149.0,24.5,18-68,18.0,68.0,,0,8650,9157,4115625
272,healthy,healthy,male,123.0,,24.4,18-61,18.0,61.0,,0,8650,9157,4115625
15,Autism Spectrum Disorder,patients,ASD,12.0,3.0,38.0,,,,,0,10521,12299,2648877
18,non-autistic,healthy,control,13.0,5.0,32.0,,,,,0,10521,12299,2648877
75,chronic dieters,patients,females,,75.0,19.38,18-23,18.0,23.0,,0,11781,12827,5460048
20,healthy,healthy,all,16.0,4.0,,20-36,20.0,36.0,,0,6158,6634,4717328
12,normal or corrected-to-normal vision and reported no prior psychiatric or neurological impairments,healthy,adults,6.0,6.0,25.4,20-40,20.0,40.0,,0,9653,9985,2151069
20,unipolar major depression,patients,primary study,,,,,,,,1,15035,15652,5416685
19,unipolar major depression,patients,validation study,,,,,,,,1,15035,15652,5416685
19,healthy,healthy,primary sample,,,,,,,,1,15035,15652,5416685
20,healthy,healthy,validation sample,,,,,,,,1,15035,15652,5416685
11,"normal or corrected-to-normal vision, and none of them had neurological or psychiatric disorders",healthy,Experiment 1 and 2,8.0,3.0,33.1,25-47,25.0,47.0,,0,9509,10064,6328158
46,schizophrenia,patients,"drug-naive, first-episode schizophrenia",,,,18-37,18.0,37.0,,0,10028,11436,6197719
46,,healthy,unaffected siblings,,,,18-37,18.0,37.0,,0,10028,11436,6197719
46,,healthy,controls,,,,18-37,18.0,37.0,,0,10028,11436,6197719
223,mood and/or anxiety disorder,patients,MA,61.0,162.0,36.0,,,,,0,14245,15404,7082218
45,healthy control,healthy,HC,22.0,23.0,32.0,,,,,0,14245,15404,7082218
147,MDD,patients,depression group,50.0,97.0,,18-45,18.0,45.0,,0,7260,8990,5598991
130,healthy,healthy,healthy control group,49.0,81.0,,,,,,0,7260,8990,5598991
39,mild WMHs,patients,mild WMHs,,,,40-80,40.0,80.0,,8,7631,9960,8315277
37,moderate WMHs,patients,moderate WMHs,,,,40-80,40.0,80.0,,8,7631,9960,8315277
28,severe WMHs,patients,severe WMHs,,,,40-80,40.0,80.0,,8,7631,9960,8315277
37,healthy,healthy,HCs,,,,,,,,8,7631,9960,8315277
19,ADHD,patients,ADHD alone,,,,,,,,5,7824,10005,4936600
6,DCD,patients,DCD alone,,,,,,,,5,7824,10005,4936600
14,DCD+ADHD,patients,DCD+ADHD,,,,,,,,5,7824,10005,4936600
21,Typically developing,healthy,Typically developing,,,,,,,,5,7824,10005,4936600
539,ASD,patients,ASD patients from ABIDE I,,,,,,,,2,29835,31498,9407088
573,healthy,healthy,Normal controls from ABIDE I,,,,,,,,2,29835,31498,9407088
521,ASD,patients,ASD patients from ABIDE II,,,,,,,,2,29835,31498,9407088
593,healthy,healthy,Normal controls from ABIDE II,,,,,,,,2,29835,31498,9407088
51,healthy,adults,Study 1 (Behavioral),10.0,41.0,43.71,27.49-55.91,27.49,55.91,,0,9809,11672,6664004
53,healthy,adolescents,Study 1 (Behavioral),26.0,27.0,13.37,12.18-14.82,12.18,14.82,,0,9809,11672,6664004
51,healthy,adolescents,Study 2 (fMRI),26.0,25.0,13.98,12.03-15.94,12.03,15.94,,0,9809,11672,6664004
23,healthy,healthy,total,18.0,5.0,22.0,,,,,0,10707,11145,4330553
34,healthy,healthy,students,19.0,15.0,,18-25,18.0,25.0,,0,11176,11873,6908964
7,Healthy,healthy,pre and post 10-day HCD,2.0,5.0,31.2,,,,,0,6078,7557,7758977
6,Healthy,healthy,pre and post 10-day fast,1.0,5.0,29.1,,,,,0,6078,7557,7758977
24,healthy,healthy,students from Aachen University,12.0,12.0,,,,,,0,7514,9365,3362560
20,No history of neurological disorders,healthy,All participants,9.0,11.0,23.0,18-27,18.0,27.0,,0,6763,7761,7339141
40,healthy,healthy,male,8.0,,,25-63,25.0,63.0,,0,6637,7668,8172304
40,healthy,healthy,female,,32.0,,25-63,25.0,63.0,,0,6637,7668,8172304
32,chronic urticaria,patients,male,6.0,,,25-65,25.0,65.0,,0,6637,7668,8172304
32,chronic urticaria,patients,female,,26.0,,25-65,25.0,65.0,,0,6637,7668,8172304
15,healthy,healthy,undergraduate students,10.0,5.0,,20-22,20.0,22.0,,0,9041,9577,6989437
14,PTSD,patients,PTSD patients,,,,,,,,0,15850,17312,8785646
15,Healthy,healthy,Healthy participants,,,,,,,,0,15850,17312,8785646
20,healthy,healthy,ASU students,1.0,19.0,21.4,18-31,18.0,31.0,,0,16503,17874,6136263
102,healthy,healthy,Oulu dataset,36.0,66.0,21.5,20 to 23,20.0,23.0,,1,8012,9221,3775427
121,panic disorder and agoraphobia,patients,first funding period,,,,,,,,1,8576,10681,6854061
77,healthy,healthy,first funding period,,,,,,,,1,8576,10681,6854061
113,panic disorder and agoraphobia,patients,second funding period,,,,,,,,1,8576,10681,6854061
99,healthy,healthy,second funding period,,,,,,,,1,8576,10681,6854061
20,fibromyalgia,patients,FM,,20.0,46.4,22-70,22.0,70.0,,0,5393,6615,6820536
20,healthy,healthy,HC,,20.0,42.1,21-70,21.0,70.0,,0,5393,6615,6820536
18,healthy,healthy,students from Lyon University,8.0,,22.5,,,,,0,14874,15604,6344389
40,healthy,healthy,2/3 and 3/4 APOE genotype,,,,18 - 23,18.0,23.0,,0,5472,7428,3520927
57,A1 trauma,patients,all participants,22.0,35.0,21.9,18-37,18.0,37.0,,0,14405,15358,6024199
21,PTSD,patients,PTSD group,6.0,15.0,21.5,18-31,18.0,31.0,,0,14405,15358,6024199
21,A1 trauma,healthy,trauma-exposed control group,7.0,14.0,22.1,18-37,18.0,37.0,,0,14405,15358,6024199
26,ASD,patients,ASD,,,,,,,,1,9309,10707,7194032
28,Typically Developing,healthy,TD,,,,,,,,1,9309,10707,7194032
70,BD,patients,BD patients in partial or full remission,,,37.0,18-65,18.0,65.0,,0,7076,8109,6908505
44,chronic osteoarthritis in the right and/or left knee,patients,acupuncture naive patients,25.0,19.0,,43-70,43.0,70.0,,1,19248,20025,4175730
30,chronic osteoarthritis in the right and/or left knee,patients,completed all study procedures,17.0,13.0,,,,,,1,19248,20025,4175730
14,chronic osteoarthritis in the right and/or left knee,patients,did not complete the study,,,,,,,,1,19248,20025,4175730
46,,healthy,KAIST volunteers,32.0,14.0,22.61,,,,,0,9299,9595,7745153
30,"ADHD, hyperactive-impulsive/inattentive combined subtype",patients,ADHD boys,30.0,,,10-17,10.0,17.0,,0,9065,10833,4190683
30,Healthy,healthy,Healthy control boys,30.0,,,10-17,10.0,17.0,,0,9065,10833,4190683
22,healthy,healthy,Experiment 1,17.0,5.0,,19-41,19.0,41.0,,0,5763,6450,4349631
16,healthy,healthy,Experiment 2,11.0,5.0,,20-59,20.0,59.0,,0,5763,6450,4349631
163,healthy,healthy,male,117.0,,36.9,,,,,1,12727,14370,6611425
163,healthy,healthy,female,,46.0,36.9,,,,,1,12727,14370,6611425
151,SZ,patients,male,114.0,,37.8,,,,,1,12727,14370,6611425
151,SZ,patients,female,,37.0,37.8,,,,,1,12727,14370,6611425
26,typically developing,healthy,Caucasian children and adolescents,17.0,9.0,11.42,8-16,8.0,16.0,,0,7835,9334,7005761
16,healthy,healthy,total,,7.0,,18-35,18.0,35.0,,0,28053,28467,3183226
133,ischemic stroke,patients,all patients,,,,60-70,60.0,70.0,,1,7175,9128,5665859
72,ischemic stroke,patients,patients who participated in the study,,,,60-70,60.0,70.0,,1,7175,9128,5665859
22,healthy,healthy,fMRI participants,11.0,11.0,23.33,,,,,0,17562,19091,6215330
24,healthy,healthy,EEG participants,12.0,12.0,25.07,,,,,0,17562,19091,6215330
21,healthy,healthy,Final EEG participants,9.0,12.0,26.76,,,,,0,17562,19091,6215330
28,schizophrenia,patients,Sz,,,,21-54,21.0,54.0,,0,7464,8764,8883821
20,autism spectrum disorder,patients,ASD,,,,19-43,19.0,43.0,,0,7464,8764,8883821
30,neurotypical controls,healthy,controls,,,,19-54,19.0,54.0,,0,7464,8764,8883821
14,AD,patients,AD patients,,,,,,,,0,6223,7943,3423412
8,MCI,patients,MCI patients,,,,,,,,0,6223,7943,3423412
14,healthy,healthy,healthy controls,,,,,,,,0,6223,7943,3423412
25,postpartum,patients,postpartum group,,25.0,,2 to 4 months postpartum,,,,0,23741,25117,7272423
32,healthy,healthy,control group,,32.0,,,,,,0,23741,25117,7272423
16,DLB,patients,DLB patients,,,,,,,,0,7293,9018,3984441
17,healthy,healthy,controls,,,,,,,,0,7293,9018,3984441
16,asymptomatic carotid artery stenosis,patients,N/A,,,,55-80,55.0,80.0,,1,3930,5250,5552726
